Metraipolis › archive › dc_7db9fe4f28f2
FDA-Approved Passive Immunization Treatments Against Aβ in Alzheimer's Disease: Where Are We Now? — Europe PMC PMID:41596530
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41596530
- DOI
- 10.3390/ijms27020883
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T19:15:28.389Z
- SHA-256 of the archived text
70efd3b381aeda3f48292a721dd6c561825aa4fd6410cd41a23b7ed3a85c6403- Stable URL of this page
https://metraipolis.com/documento/dc_7db9fe4f28f2
How to cite
FDA-Approved Passive Immunization Treatments Against Aβ in Alzheimer's Disease: Where Are We Now? — Europe PMC PMID:41596530 — Europe PMC (en), https://europepmc.org/article/MED/41596530 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7db9fe4f28f2 (Metraipolis archive dc_7db9fe4f28f2, sha256 70efd3b381aeda3f48292a721dd6c561825aa4fd6410cd41a23b7ed3a85c6403)
BibTeX
@misc{dc7db9fe4f28f2,
title = {FDA-Approved Passive Immunization Treatments Against Aβ in Alzheimer's Disease: Where Are We Now? — Europe PMC PMID:41596530},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41596530},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7db9fe4f28f2; sha256 70efd3b381aeda3f48292a721dd6c561825aa4fd6410cd41a23b7ed3a85c6403},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41596530. Agents can read the archived copy with the MCP tool read_document.